Hudson Bay Capital Management LP 13D/13G Filings for Ibere Pharmaceuticals (IBER)

Hudson Bay Capital Management LP 13D and 13G filings for Ibere Pharmaceuticals:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2023-02-08
3:19 pm
Purchase
2022-12-31 13G Ibere Pharmaceuticals
IBER
Hudson Bay Capital Management LP 716,613
5.190%
716,613increase
(New Position)
Filing